Annual Long Term Debt
$5.30 M
+$3.82 M+258.35%
31 December 2023
Summary:
Mereo BioPharma annual long term debt is currently $5.30 million, with the most recent change of +$3.82 million (+258.35%) on 31 December 2023. During the last 3 years, it has fallen by -$18.28 million (-77.52%). MREO annual long term debt is now -79.15% below its all-time high of $25.42 million, reached on 31 December 2017.MREO Long Term Debt Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Long Term Debt
$394.00 K
-$158.00 K-28.62%
30 September 2024
Summary:
Mereo BioPharma quarterly long term debt is currently $394.00 thousand, with the most recent change of -$158.00 thousand (-28.62%) on 30 September 2024. MREO quarterly long term debt is now -98.75% below its all-time high of $31.60 million, reached on 30 June 2020.MREO Quarterly Long Term Debt Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
MREO Long Term Debt Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +258.4% | - |
| 3 y3 years | -77.5% | -98.6% |
| 5 y5 years | -71.5% | -98.8% |
MREO Long Term Debt High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | -77.5% | +258.4% | -98.6% | at low |
| 5 y | 5 years | -77.5% | +258.4% | -98.8% | at low |
| alltime | all time | -79.2% | -98.8% |
Mereo BioPharma Long Term Debt History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $394.00 K(-28.6%) |
| June 2024 | - | $552.00 K(-24.1%) |
| Mar 2024 | - | $727.00 K(-86.3%) |
| Dec 2023 | $5.30 M(+258.4%) | $5.30 M(-9.4%) |
| June 2023 | - | $5.85 M(+295.5%) |
| Dec 2022 | $1.48 M(-93.2%) | $1.48 M(-16.3%) |
| June 2022 | - | $1.77 M(-91.9%) |
| Dec 2021 | $21.78 M(-7.6%) | $21.78 M(-20.9%) |
| June 2021 | - | $27.52 M(+16.7%) |
| Dec 2020 | $23.58 M | $23.58 M(-25.4%) |
| Date | Annual | Quarterly |
|---|---|---|
| June 2020 | - | $31.60 M(+64.1%) |
| Dec 2019 | $19.26 M(+3.6%) | $19.26 M(-38.9%) |
| June 2019 | - | $31.50 M(+69.5%) |
| Dec 2018 | $18.59 M(-26.9%) | $18.59 M(-6.8%) |
| June 2018 | - | $19.95 M(-21.5%) |
| Dec 2017 | $25.42 M(+559.1%) | $25.42 M(+905.4%) |
| June 2017 | - | $2.53 M(-34.4%) |
| Dec 2016 | $3.86 M(>+9900.0%) | $3.86 M(-2.3%) |
| June 2016 | - | $3.95 M(>+9900.0%) |
| Dec 2015 | $0.00 | $0.00 |
FAQ
- What is Mereo BioPharma annual long term debt?
- What is the all time high annual long term debt for Mereo BioPharma?
- What is Mereo BioPharma annual long term debt year-on-year change?
- What is Mereo BioPharma quarterly long term debt?
- What is the all time high quarterly long term debt for Mereo BioPharma?
What is Mereo BioPharma annual long term debt?
The current annual long term debt of MREO is $5.30 M
What is the all time high annual long term debt for Mereo BioPharma?
Mereo BioPharma all-time high annual long term debt is $25.42 M
What is Mereo BioPharma annual long term debt year-on-year change?
Over the past year, MREO annual long term debt has changed by +$3.82 M (+258.35%)
What is Mereo BioPharma quarterly long term debt?
The current quarterly long term debt of MREO is $394.00 K
What is the all time high quarterly long term debt for Mereo BioPharma?
Mereo BioPharma all-time high quarterly long term debt is $31.60 M